Last reviewed · How we verify
NCT07349589
Evaluate the Safety, Tolerability and Pharmacokinetics of DW5524 in Healthy Adult Volunteers
Phase 1 trial testing DW5524 in Healthy Adult in 48 participants. Not yet recruiting.
28 February 2026
Quick facts
| Lead sponsor | Daewon Pharmaceutical Co., Ltd. |
|---|---|
| Phase | Phase 1 |
| Status | Not yet recruiting |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 48 |
| Start date | 1 February 2026 |
| Primary completion | 28 February 2026 |
| Estimated completion | 1 December 2026 |
| Sites | 1 location across South Korea |
Drugs / interventions tested
Conditions studied
- Healthy Adult — all drugs for Healthy Adult →
Sponsor
Daewon Pharmaceutical Co., Ltd. — full company profile →
Who can join
19 and older, any sex, with Healthy Adult. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study aimed to evaluate the safety and pharmacokinetic characteristics of DW5524 in healthy adult volunteers.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT07349589
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Healthy Adult
Currently open trials in the same condition.
- NCT07361406 — SweetSpot - The Effect of Non-nutritive Sweeteners on Health · NA · recruiting
- NCT07393841 — Molecular Indicators of Systematic Fitness · recruiting
- NCT07343245 — A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs · Phase 1 · recruiting
- NCT07414862 — The Effects of Finger Extensor Training on Climbing Performance Compared With Traditional Flexor Training · NA · active not recruiting
- NCT07527247 — Improving Vaccine Protection for Older Adults · Phase 2 · recruiting
Other Daewon Pharmaceutical Co., Ltd. trials
Trials by the same sponsor.
- NCT07364851 — A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421-T1 and DW4421S-T1 in Healthy Adult Volunt · Phase 1 · not yet recruiting
- NCT07364877 — A Phase 1 Clinical Trial to Evaluate the Safety and Pharmacokinetics of DW4421 and DW4421S in Healthy Adult Volunteers · Phase 1 · enrolling by invitation
- NCT07343245 — A Phase 1 Clinical Trial to Evaluate the Safety and DDI of DW4421 and 3 NSAIDs · Phase 1 · recruiting
- NCT07319559 — Clinical Trial to Evaluate the Safety, Pharmacokinetic Characteristics of DW5124 and DW5124-R, and the Effect of Food on · Phase 1 · completed
- NCT07444762 — Clinical Trial to Evaluate the Efficacy and Safety of Combination Therapy of DW5421A/DW5421B Compared to Monotherapy of · Phase 3 · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07349589 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Daewon Pharmaceutical Co., Ltd.
- Last refreshed: 20 January 2026
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07349589.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing